{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:54:31Z","timestamp":1793145271093,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T00:00:00Z","timestamp":1592956800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T00:00:00Z","timestamp":1592956800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:sec>\n<jats:title>Abstract<\/jats:title>\n<\/jats:sec><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) and two stage hepatectomy with inter-stage portal vein embolization (TSH\/PVE) are surgical maneuvers applied in patients with advanced malignancies considered unresectable by means of conventional liver surgery. The aim of this report is to compare the oncologic outcome and technical feasibility of ALPPS and TSH\/PVE in the scenario of colorectal liver metastases (CRLM).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>All consecutive patients who underwent either ALPPS or TSH\/PVE for CRLM between 2011 and 2017 in one hepatobiliary center were analyzed and compared regarding perioperative and long-term oncologic outcome.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>A cohort of 58 patients who underwent ALPPS (<jats:italic>n<\/jats:italic> = 21) or TSH\/PVE (<jats:italic>n<\/jats:italic> = 37) was analyzed. The median overall survival (OS) was 28\u2009months and 34\u2009months after ALPPS and TSH\/PVE (<jats:italic>p<\/jats:italic> = 0.963), respectively. The median recurrence-free survival (RFS) was higher following ALPPS with 19\u2009months than following TSH\/PVE with 10\u2009months, but marginally failed to achieve statistical significance (<jats:italic>p<\/jats:italic> = 0.05). There were no differences in morbidity and mortality after stages 1 and 2. Patients undergoing ALPPS due to insufficient hypertrophy after TSH\/PVE (rescue-ALPPS) displayed similar oncologic outcome as patients treated by conventional ALPPS or TSH\/PVE (<jats:italic>p<\/jats:italic> = 0.971).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>ALPPS and TSH\/PVE show excellent technical feasibility and comparable long-term oncologic outcome in CRLM. Rescue ALPPS appears to be a viable option for patients displaying insufficient hypertrophy after a TSH\/PVE approach.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12957-020-01919-3","type":"journal-article","created":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T20:02:48Z","timestamp":1593028968000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["ALPPS versus two-stage hepatectomy for colorectal liver metastases\u2014\u2013a comparative retrospective cohort study"],"prefix":"10.1186","volume":"18","author":[{"given":"Jan","family":"Bednarsch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoltan","family":"Czigany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samara","family":"Sharmeen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"van der Kroft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Strnad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom Florian","family":"Ulmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Isfort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Bruners","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9674-0756","authenticated-orcid":false,"given":"Georg","family":"Lurje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf Peter","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,24]]},"reference":[{"key":"1919_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69\u201390.","journal-title":"CA Cancer J Clin"},{"key":"1919_CR2","first-page":"283","volume":"4","author":"GP Kanas","year":"2012","unstructured":"Kanas GP, Taylor A, Primrose JN, Langeberg WJ, Kelsh MA, Mowat FS, et al. Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors. Clin Epidemiol. 2012;4:283\u2013301.","journal-title":"Clin Epidemiol"},{"key":"1919_CR3","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1093\/annonc\/mdw235","volume":"27","author":"E Van Cutsem","year":"2016","unstructured":"Van Cutsem E, Cervantes A, Adam R, Sobrero A, Van Krieken JH, Aderka D, et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol. 2016;27:1386\u2013422.","journal-title":"Ann Oncol"},{"key":"1919_CR4","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1097\/SLA.0b013e31824856f5","volume":"255","author":"AA Schnitzbauer","year":"2012","unstructured":"Schnitzbauer AA, Lang SA, Goessmann H, Nadalin S, Baumgart J, Farkas SA, et al. Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann Surg. 2012;255:405\u201314.","journal-title":"Ann Surg"},{"key":"1919_CR5","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1097\/SLA.0000000000001633","volume":"263","author":"KJ Oldhafer","year":"2016","unstructured":"Oldhafer KJ, Stavrou GA, van Gulik TM, Core G. ALPPS--where do we stand, where do we go?: eight recommendations from the first international expert meeting. Ann Surg. 2016;263:839\u201341.","journal-title":"Ann Surg"},{"key":"1919_CR6","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1097\/00000658-200012000-00006","volume":"232","author":"R Adam","year":"2000","unstructured":"Adam R, Laurent A, Azoulay D, Castaing D, Bismuth H. Two-stage hepatectomy: a planned strategy to treat irresectable liver tumors. Ann Surg. 2000;232:777\u201385.","journal-title":"Ann Surg"},{"key":"1919_CR7","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.jamcollsurg.2014.01.063","volume":"219","author":"F Giuliante","year":"2014","unstructured":"Giuliante F, Ardito F, Ferrero A, Aldrighetti L, Ercolani G, Grande G, et al. Tumor progression during preoperative chemotherapy predicts failure to complete 2-stage hepatectomy for colorectal liver metastases: results of an Italian multicenter analysis of 130 patients. J Am Coll Surg. 2014;219:285\u201394.","journal-title":"J Am Coll Surg"},{"key":"1919_CR8","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1097\/SLA.0000000000001449","volume":"262","author":"K Imai","year":"2015","unstructured":"Imai K, Benitez CC, Allard MA, Vibert E, Cunha AS, Cherqui D, et al. Failure to achieve a 2-stage hepatectomy for colorectal liver metastases: how to prevent it? Ann Surg. 2015;262:772\u20138 discussion 778-779.","journal-title":"Ann Surg"},{"key":"1919_CR9","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1097\/SLA.0000000000000947","volume":"260","author":"E Schadde","year":"2014","unstructured":"Schadde E, Ardiles V, Robles-Campos R, Malago M, Machado M, Hernandez-Alejandro R, et al. Early survival and safety of ALPPS: first report of the international ALPPS registry. Ann Surg. 2014;260:829\u201336 discussion 836-828.","journal-title":"Ann Surg"},{"key":"1919_CR10","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1002\/bjs.10256","volume":"103","author":"R Adam","year":"2016","unstructured":"Adam R, Imai K, Castro Benitez C, Allard MA, Vibert E, Sa Cunha A, et al. Outcome after associating liver partition and portal vein ligation for staged hepatectomy and conventional two-stage hepatectomy for colorectal liver metastases. Br J Surg. 2016;103:1521\u20139.","journal-title":"Br J Surg"},{"key":"1919_CR11","doi-asserted-by":"crossref","unstructured":"Baumgart J, Jungmann F, Bartsch F, Kloth M, Mittler J, Heinrich S, et al. Two-stage hepatectomy and ALPPS for advanced bilateral liver metastases: a tailored approach balancing risk and outcome. J Gastrointest Surg. 2019.","DOI":"10.1007\/s11605-019-04145-9"},{"key":"1919_CR12","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1097\/SLA.0000000000002511","volume":"267","author":"P Sandstrom","year":"2018","unstructured":"Sandstrom P, Rosok BI, Sparrelid E, Larsen PN, Larsson AL, Lindell G, et al. ALPPS improves resectability compared with conventional two-stage hepatectomy in patients with advanced colorectal liver metastasis: results from a Scandinavian multicenter randomized controlled trial (LIGRO trial). Ann Surg. 2018;267:833\u201340.","journal-title":"Ann Surg"},{"key":"1919_CR13","doi-asserted-by":"publisher","first-page":"3915","DOI":"10.1245\/s10434-016-5419-5","volume":"23","author":"P Kambakamba","year":"2016","unstructured":"Kambakamba P, Linecker M, Alvarez FA, Samaras P, Reiner CS, Raptis DA, et al. Short chemotherapy-free interval improves oncological outcome in patients undergoing two-stage hepatectomy for colorectal liver metastases. Ann Surg Oncol. 2016;23:3915\u201323.","journal-title":"Ann Surg Oncol"},{"key":"1919_CR14","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s00423-019-01838-2","volume":"404","author":"J Bednarsch","year":"2019","unstructured":"Bednarsch J, Czigany Z, Lurje I, Strnad P, Bruners P, Ulmer TF, et al. The role of ALPPS in intrahepatic cholangiocarcinoma. Langenbeck's Arch Surg. 2019;404:885\u201394.","journal-title":"Langenbeck's Arch Surg"},{"key":"1919_CR15","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1016\/j.ejso.2019.04.019","volume":"45","author":"G Lurje","year":"2019","unstructured":"Lurje G, Bednarsch J, Czigany Z, Lurje I, Schlebusch IK, Boecker J, et al. The prognostic role of lymphovascular invasion and lymph node metastasis in perihilar and intrahepatic cholangiocarcinoma. Eur J Surg Oncol. 2019;45:1468\u201378.","journal-title":"Eur J Surg Oncol"},{"key":"1919_CR16","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1007\/s00268-016-3662-3","volume":"41","author":"TF Ulmer","year":"2017","unstructured":"Ulmer TF, de Jong C, Andert A, Bruners P, Heidenhain CM, Schoening W, et al. ALPPS procedure in insufficient hypertrophy after portal vein embolization (PVE). World J Surg. 2017;41:250\u20137.","journal-title":"World J Surg"},{"key":"1919_CR17","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.surg.2016.10.032","volume":"161","author":"PB Olthof","year":"2017","unstructured":"Olthof PB, Huiskens J, Wicherts DA, Huespe PE, Ardiles V, Robles-Campos R, et al. Survival after associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) for advanced colorectal liver metastases: a case-matched comparison with palliative systemic therapy. Surgery. 2017;161:909\u201319.","journal-title":"Surgery"},{"key":"1919_CR18","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1097\/SLA.0000000000000786","volume":"261","author":"S Dueland","year":"2015","unstructured":"Dueland S, Guren TK, Hagness M, Glimelius B, Line PD, Pfeiffer P, et al. Chemotherapy or liver transplantation for nonresectable liver metastases from colorectal cancer? Ann Surg. 2015;261:956\u201360.","journal-title":"Ann Surg"},{"key":"1919_CR19","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1200\/JCO.2011.38.0915","volume":"30","author":"KM Tveit","year":"2012","unstructured":"Tveit KM, Guren T, Glimelius B, Pfeiffer P, Sorbye H, Pyrhonen S, et al. Phase III trial of cetuximab with continuous or intermittent fluorouracil, leucovorin, and oxaliplatin (Nordic FLOX) versus FLOX alone in first-line treatment of metastatic colorectal cancer: the NORDIC-VII study. J Clin Oncol. 2012;30:1755\u201362.","journal-title":"J Clin Oncol"},{"key":"1919_CR20","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1007\/s00268-017-4181-6","volume":"42","author":"D Moris","year":"2018","unstructured":"Moris D, Ronnekleiv-Kelly S, Kostakis ID, Tsilimigras DI, Beal EW, Papalampros A, et al. Operative results and oncologic outcomes of associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) versus two-stage hepatectomy (TSH) in patients with unresectable colorectal liver metastases: a systematic review and meta-analysis. World J Surg. 2018;42:806\u201315.","journal-title":"World J Surg"},{"key":"1919_CR21","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1245\/s10434-014-4291-4","volume":"22","author":"F Ratti","year":"2015","unstructured":"Ratti F, Schadde E, Masetti M, Massani M, Zanello M, Serenari M, et al. Strategies to increase the resectability of patients with colorectal liver metastases: a multi-center case-match analysis of ALPPS and conventional two-stage hepatectomy. Ann Surg Oncol. 2015;22:1933\u201342.","journal-title":"Ann Surg Oncol"},{"key":"1919_CR22","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1002\/bjs.9547","volume":"101","author":"R Robles","year":"2014","unstructured":"Robles R, Parrilla P, Lopez-Conesa A, Brusadin R, de la Pena J, Fuster M, et al. Tourniquet modification of the associating liver partition and portal ligation for staged hepatectomy procedure. Br J Surg. 2014;101:1129\u201334 discussion 1134.","journal-title":"Br J Surg"},{"key":"1919_CR23","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1097\/SLA.0b013e318283a4d1","volume":"257","author":"A Andreou","year":"2013","unstructured":"Andreou A, Aloia TA, Brouquet A, Dickson PV, Zimmitti G, Maru DM, et al. Margin status remains an important determinant of survival after surgical resection of colorectal liver metastases in the era of modern chemotherapy. Ann Surg. 2013;257:1079\u201388.","journal-title":"Ann Surg"},{"key":"1919_CR24","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1245\/s10434-016-5609-1","volume":"24","author":"GA Margonis","year":"2017","unstructured":"Margonis GA, Sasaki K, Andreatos N, Kim Y, Merath K, Wagner D, et al. KRAS mutation status dictates optimal surgical margin width in patients undergoing resection of colorectal liver metastases. Ann Surg Oncol. 2017;24:264\u201371.","journal-title":"Ann Surg Oncol"},{"key":"1919_CR25","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/j.ejso.2013.08.009","volume":"39","author":"C Tschuor","year":"2013","unstructured":"Tschuor C, Croome KP, Sergeant G, Cano V, Schadde E, Ardiles V, et al. Salvage parenchymal liver transection for patients with insufficient volume increase after portal vein occlusion -- an extension of the ALPPS approach. Eur J Surg Oncol. 2013;39:1230\u20135.","journal-title":"Eur J Surg Oncol"},{"key":"1919_CR26","doi-asserted-by":"crossref","unstructured":"Hasselgren K, Rosok BI, Larsen PN, Sparrelid E, Lindell G, Schultz NA, et al. ALPPS improves survival compared with TSH in patients affected of CRLM: survival analysis from the randomized controlled trial LIGRO. Ann Surg. 2019.","DOI":"10.1097\/SLA.0000000000004014"},{"key":"1919_CR27","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/hpb.12386","volume":"17","author":"KP Croome","year":"2015","unstructured":"Croome KP, Hernandez-Alejandro R, Parker M, Heimbach J, Rosen C, Nagorney DM. Is the liver kinetic growth rate in ALPPS unprecedented when compared with PVE and living donor liver transplant? A multicentre analysis. HPB (Oxford). 2015;17:477\u201384.","journal-title":"HPB (Oxford)"},{"key":"1919_CR28","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.surg.2015.12.004","volume":"159","author":"K Matsuo","year":"2016","unstructured":"Matsuo K, Murakami T, Kawaguchi D, Hiroshima Y, Koda K, Yamazaki K, et al. Histologic features after surgery associating liver partition and portal vein ligation for staged hepatectomy versus those after hepatectomy with portal vein embolization. Surgery. 2016;159:1289\u201398.","journal-title":"Surgery"},{"key":"1919_CR29","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1097\/SLA.0000000000002797","volume":"269","author":"H Lang","year":"2019","unstructured":"Lang H, de Santibanes E, Schlitt HJ, Malago M, van Gulik T, Machado MA, et al. 10th anniversary of ALPPS-lessons learned and quo Vadis. Ann Surg. 2019;269:114\u20139.","journal-title":"Ann Surg"},{"key":"1919_CR30","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/00000658-199909000-00004","volume":"230","author":"Y Fong","year":"1999","unstructured":"Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999;230:309\u201318 discussion 318-321.","journal-title":"Ann Surg"},{"key":"1919_CR31","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1159\/000381755","volume":"32","author":"EP van der Stok","year":"2015","unstructured":"van der Stok EP, Grunhagen DJ, Alberda WJ, Reitsma M, Rothbarth J, Verhoef C. The prognostic value of the primary tumor\u2019s nodal status after surgery for colorectal liver metastases in the era of effective systemic therapy. Dig Surg. 2015;32:208\u201316.","journal-title":"Dig Surg"},{"key":"1919_CR32","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s11605-013-2329-8","volume":"18","author":"AA Thomay","year":"2014","unstructured":"Thomay AA, Nagorney DM, Cohen SJ, Sigurdson ER, Truty MJ, Burtness B, et al. Modern chemotherapy mitigates adverse prognostic effect of regional nodal metastases in stage IV colorectal cancer. J Gastrointest Surg. 2014;18:69\u201374.","journal-title":"J Gastrointest Surg"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-020-01919-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-020-01919-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-020-01919-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T23:49:52Z","timestamp":1624492192000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-020-01919-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,24]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1919"],"URL":"https:\/\/doi.org\/10.1186\/s12957-020-01919-3","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,24]]},"assertion":[{"value":"13 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The need for ethics approval and consent was waived by the Institutional Review Board of the RWTH Aachen University due to the retrospective nature of the study (EK 341\/19).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors report no conflict for interest for this research paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"140"}}